Improving IO and Oncology Outcomes from Preclinical to Translation
September 25 - 27, 2018
Developing a Mouse Tumor Homograft Model Platform (MuPrimeTM) for Immuno-Oncology Drug Discovery
Wednesday September 26th, 10:10-10:40am
Learn more about murine tumor homograft models, which are derived from GEMM spontaneous tumors, and recapitulate human tumors both morphologically and with clinically relevant oncogenic drivers. Discover the diverse spectrum of tumor microenvironments MuPrime models offer for testing a variety of immunotherapeutic agents.